The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
With its unique combination of AI, population-specific research, and international collaboration, BioMed X’s Barbados project represents a bold new frontier in precision medicine for diabetes and kidney disease
A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
The acquisition combines Firstsource’s market-leading AI and automation capabilities with TeleMedik’s operational footprint in Puerto Rico
The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
The therapy is mutation-agnostic and aims to overcome limitations of existing EGFR-targeting drugs by concentrating degradation in tumors while sparing healthy tissue
Subscribe To Our Newsletter & Stay Updated
